Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surveillance and Early Detection of Esophageal Squamous Cell Carcinoma With Minimally-invasive Cytosponge™ Cell Collection Device Coupled With Molecular Biomarkers

NCT04192695 is registered in ClinicalTrials.gov with Centre of Postgraduate Medical Education as lead sponsor.

NCT NCT04192695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04192695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surveillance and Early Detection of Esophageal Squamous Cell Carcinoma With Minimally-invasive Cytosponge™ Cell Collection Device Coupled With Molecular Biomarkers
Lead sponsor
Centre of Postgraduate Medical Education
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2021
Completion date
May 1, 2024
Enrollment
178 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer